| Patent | Date |
|---|
Substituted heterocycles for the treatment of diabetes and other diseases
Grant 7,226,940 - Pfahl , et al. June 5, 2 | 2007-06-05 |
Bicyclic heterocycles for the treatment of diabetes and other diseases
Grant 7,196,108 - Pfahl , et al. March 27, 2 | 2007-03-27 |
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
Grant 7,153,875 - Pfahl , et al. December 26, 2 | 2006-12-26 |
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
App 20060160796 - Pfahl; Magnus ; et al. | 2006-07-20 |
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
Grant 7,071,218 - Pfahl , et al. July 4, 2 | 2006-07-04 |
Substituted heterocycles for the treatment of diabetes and other diseases
App 20060004059 - Pfahl; Magnus ; et al. | 2006-01-05 |
Imidazolidinedione derivatives for the treatment of diabetes and other diseases
Grant 6,974,826 - Pfahl , et al. December 13, 2 | 2005-12-13 |
RXR activating molecules
App 20050209286 - Pfahl, Magnus ; et al. | 2005-09-22 |
Imidazolidinedione derivatives for the treatment of diabetes and other diseases
App 20050070581 - Pfahl, Magnus ; et al. | 2005-03-31 |
Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
App 20050014767 - Pfahl, Magnus ; et al. | 2005-01-20 |
Thiazolidinedione derivatives for the treatment of diabetes and other diseases
Grant 6,765,013 - Pfahl , et al. July 20, 2 | 2004-07-20 |
2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
App 20040097566 - Pfahl, Magnus ; et al. | 2004-05-20 |
Bicyclic heterocycles for the treatment of diabetes and other diseases
App 20040034004 - Pfahl, Magnus ; et al. | 2004-02-19 |
Serine protease inhibitors
Grant 6,656,910 - Gyorkos , et al. December 2, 2 | 2003-12-02 |
Serine protease inhibitors
Grant 6,656,911 - Gyorkos , et al. December 2, 2 | 2003-12-02 |
Serine Protease Inhibitors
App 20030203851 - Gyorkos, Albert ; et al. | 2003-10-30 |
Serine protease inhibitors
Grant 6,608,175 - Gyorkos , et al. August 19, 2 | 2003-08-19 |
Thiazolidinedione derivatives for the treatment of diabetes and other diseases
App 20030153606 - Pfahl, Magnus ; et al. | 2003-08-14 |
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
App 20030144329 - Pfahl, Magnus ; et al. | 2003-07-31 |
RXR activating molecules
App 20030105333 - Pfahl, Magnus ; et al. | 2003-06-05 |
Serine protease inhibitors
App 20030060418 - Gyorkos, Albert ; et al. | 2003-03-27 |
Heterocyclic derivatives for the treatment of diabetes and other diseases
Grant 6,515,003 - Pfahl , et al. February 4, 2 | 2003-02-04 |
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
App 20020143182 - Pfahl, Magnus ; et al. | 2002-10-03 |
Serine protease inhibitors
App 20020119985 - Gyorkos, Albert ; et al. | 2002-08-29 |
Serine protease inhibitors
App 20020119998 - Gyorkos, Albert ; et al. | 2002-08-29 |
Serine protease inhibitors comprising .alpha.-keto heterocycles
Grant 6,159,938 - Gyorkos , et al. December 12, 2 | 2000-12-12 |
Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
Grant 6,100,238 - Gyorkos , et al. August 8, 2 | 2000-08-08 |
Bradykinin antagonist
Grant 6,075,120 - Cheronis , et al. June 13, 2 | 2000-06-13 |
Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
Grant 6,037,325 - Gyorkos , et al. March 14, 2 | 2000-03-14 |
Serine protease inhibitors-cycloheptane derivatives
Grant 6,015,791 - Gyorkos , et al. January 18, 2 | 2000-01-18 |
Cysteine protease inhibitors
Grant 6,004,933 - Spruce , et al. December 21, 1 | 1999-12-21 |
Val-pro containing .alpha.-keto oxadiazoles as serine protease inhibitors
Grant 6,001,813 - Gyorkos , et al. December 14, 1 | 1999-12-14 |
Serine protease inhibitors-cycloheptane derivatives
Grant 5,891,852 - Gyorkos , et al. April 6, 1 | 1999-04-06 |
Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
Grant 5,874,585 - Gyorkos , et al. February 23, 1 | 1999-02-23 |
Serine protease inhibitors-N-substituted derivatives
Grant 5,869,455 - Gyorkos , et al. February 9, 1 | 1999-02-09 |
Bradykinin antagonists
Grant 5,863,899 - Cheronis , et al. January 26, 1 | 1999-01-26 |
Serine protease inhibitors-keto and di-keto containing ring systems
Grant 5,861,380 - Gyorkos , et al. January 19, 1 | 1999-01-19 |
Bradykinin antagonists
Grant 5,843,900 - Cheronis , et al. December 1, 1 | 1998-12-01 |
Serine protease inhibitors-proline analogs
Grant 5,801,148 - Gyorkos , et al. September 1, 1 | 1998-09-01 |
Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase
Grant 5,663,416 - Kirschenheuter , et al. September 2, 1 | 1997-09-02 |
Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
Grant 5,618,792 - Gyorkos , et al. April 8, 1 | 1997-04-08 |
Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase
Grant 5,214,191 - Kirschenheuter , et al. May 25, 1 | 1993-05-25 |
Heteroarotinoids as anticancer agents
Grant 4,833,254 - Berlin , et al. May 23, 1 | 1989-05-23 |
| 